Browse all practice questions for the US Regulatory Affairs Certification (RAC) Practice Exam. Search by topic, open any question and review its full explanation, then test yourself in the practice quiz.

US Regulatory Affairs Certification (RAC) Practice Exam course image
More practice questions

These questions are part of the practice quiz. Start practicing

  • What is an excipient in a drug formulation?
  • What are Phase IV trials specifically designed to support?
  • What did the FDA Modernization Act of 1997 (FDAMA) allow clinical study sponsors to do?
  • Which document provides the production history of a medical device?
  • How many modules is the CTD divided into?
  • What is the focus of Good Manufacturing Practice (GMP) regulations?
  • What does CTD stand for in regulatory submission?
  • What is the goal of the Streamlined PMA process?
  • Which regulatory submission does 21 CFR 314 primarily address?
  • What is the definition of an adulterated product according to FDA regulations?
  • What does GCP stand for in clinical trials?
  • What is the main focus of Phase I clinical trials?
  • What kind of subjects are typically examined in Phase I trials?
  • What is indicated by a Complete Response (CR) Letter from the FDA?
  • What is a Target Product Profile (TPP)?
  • What does it mean when a drug is marked as "Approved" by the FDA?
  • What defines pharmaceutical equivalents?
  • What is typically included in Module 1 of the CTD?
  • What does ANDA stand for in the context of drug applications?
  • Why are Phase III trials considered crucial for new drug applications?
  • What does a product Recall entail?
  • What does BLA stand for in the context of regulatory affairs?
  • What does PREA stand for?
  • What is a drug product defined as?
  • What does CPSC stand for in regulatory terms?
  • What is the processing time for an Abbreviated 510(k) submission?
  • What does NSR stand for in regulatory terms?
  • Which part outlines the requirements for labeling and good manufacturing practices?
  • What is a Drug Master File (DMF) used for?
  • What is the purpose of the FDA's Fast Track program?
  • What is the primary purpose of 21 CFR 814?
  • What is the Hatch-Waxman Act primarily known for?
  • What does a Generic Drug refer to in the context of regulatory affairs?
  • Which meeting type is defined as any meeting other than Type A or Type B?
  • What does eCTD stand for?
  • Which regulation pertains to the establishment registration and device listing for manufacturers?
  • Which aspect is addressed by 21 CFR 54?
  • What aspect of the Hatch-Waxman Act supports generic drug development?
  • What does the term 'ADME' in pharmacokinetics stand for?
  • What is the purpose of Humanitarian Use Devices as per 21 CFR 814 Subpart H?
  • What does an Annual Report to the FDA typically include?
  • What does pharmacodynamics study?
  • Which of the following does 21 CFR parts 100s cover?
  • What benefit does the Orphan Drug Act of 1983 provide to developers?
  • What does 21 CFR 807 Subpart E pertain to?
  • Which federal regulation section primarily deals with the financial interests of clinical investigators?
  • What does the Office of Combination Products (OCP) oversee?
  • What is the role of Humanitarian Use Devices under HDE?
  • What is the purpose of an Emergency Use IND?
  • What is the focus of 21 CFR 862-892?
  • What is the purpose of the eCTD?
  • What does the "regional admin information" refer to in the context of the CTD?
  • Which section covers administrative issues related to human subjects?
  • 21 CFR 312 Subpart E addresses drugs intended to treat which type of conditions?
  • What is the primary goal of the Biologics Price Competition and Innovation Act?
  • What is meant by Component in the context of drug and device manufacturing?
  • What is the purpose of 21 CFR 312?
  • What is the focus of an Investigational New Drug (IND) application?
  • A patient registry may be considered a part of which controls for certain devices?
  • What does DMEPA stand for?
  • What is the definition of a label in regulatory terms?
  • What does Module 4 of the CTD focus on?
  • What distinguishes a Traditional 510(k) from a Special 510(k)?
  • What is the aim of the 515 Program Initiative?
  • What is the purpose of a Type B meeting?
  • What is a Suitability Petition?
  • What was the primary purpose of the 1992 Medical Devices Amendments?
  • What does a Special 510(k) application primarily address?
  • What does the 30-day hold refer to in the context of IND submissions?
  • What are GMP regulations focused on?
  • What is the primary benefit of the 180-day exclusivity for ANDA applicants?
  • What is a Clinical Hold?
  • What is a market withdrawal in the context of FDA regulations?
  • What is the Primary Mode of Action (PMOA) used for in combination products?
  • What does MAF stand for in the regulatory environment?
  • What is a Modular PMA?
  • What is the purpose of the Orange Book published by the FDA?
  • In what context does a Type C meeting typically occur?
  • What does "grandfathered" refer to in regulatory terms?
  • What is contained in a Device Master Record (DMR)?
  • What distinguishes a Type A meeting from other meeting types?
  • Which term does NOT include soap in its definition according to cosmetic regulations?
  • What does pharmacovigilance primarily involve?
  • What does the 510(k) clearance process primarily demonstrate?
  • What does UADE stand for?
  • What type of meeting is typically needed to address a dispute in product development?
  • What is required during Post Marketing Surveillance (PMS)?
  • What are 21 CFR parts 200s primarily concerned with?
  • What does 21 CFR 50 aim to protect?
  • What is PMA an acronym for in regulatory affairs?
  • Which module of the CTD contains Quality documentation?
  • What does pharmacokinetics (PK) study?
  • What type of changes does the CBE-30 submission report to the FDA?
  • Which act provided FDA authority to require pediatric studies of drugs?
  • Which center is responsible for evaluating biologics?
  • In the context of FDA regulations, what is defined under 21 CFR 316?
  • What information is typically included in an action letter from the FDA?
  • What is required of an ANDA regarding bioequivalence?
  • 21 CFR 312 is critical for which aspect of drug development?
  • Which FDA review category includes drugs with faster review times compared to standard applications?
  • Which part of the regulations is focused on medical devices?
  • What is the purpose of Module 2 in the CTD?
  • Which type of application allows for drug approval based on investigations not conducted by the applicant?
  • What category is included under 21 CFR parts 500s?
  • What is the purpose of the clinical evaluation in the PDP process?
  • What does the acronym ADME stand for in pharmacology?
  • In which scenario would a 180-day exclusivity be most beneficial?
  • What is the purpose of a 120-day safety report?
  • What does substantial equivalence establish for a new device?
  • What is a Humanitarian Device Exemption (HDE)?
  • What does the Design History File (DHF) contain?
  • What does MDUFA stand for?
  • What does bioequivalence refer to in pharmaceuticals?
  • What characterizes a transitional device?
  • Which organization developed the CTD framework?
  • What is an example of a significant risk that leads to a device being classified as banned?
  • Under which act can a biological product be demonstrated to be "biosimilar"?
  • What is a requirement for Class II devices to ensure safety and effectiveness?
  • What does OCP represent in the context of the FDA?
  • What is the purpose of the De Novo Process in FDA regulations?
  • Which is a key feature of the Prescription Drug User Fee Act?
  • What is the primary focus of 21 CFR 1271?
  • What signifies a device’s classification under the De Novo process?
  • What is one characteristic of an active ingredient in bioequivalence assessment?
  • What does "Commercial Distribution" refer to?
  • What is a characteristic of the drugs listed in the Orange Book?
  • What does CFR stand for in regulatory affairs?
  • What do Post Marketing Requirements (PMR) require sponsors to conduct?
  • Which of the following describes a significant risk device?
  • What does a consent form inform potential subjects about?
  • What was a key feature of the Medical Device User Fee and Modernization Act?
  • What document might be submitted to provide detailed confidential information on drug manufacturing?
  • Which group of patients must be considered under the Pediatric Rule?
  • What is the purpose of the MAUDE database?
  • Which of the following statements accurately describes Quality System Regulations (QSR)?
  • Combination products may include which of the following?
  • What does 21 CFR 1270 regulate?
  • What is generally indicated by a clinical hold?
  • What does the Accelerated Approval pathway allow for?
  • What does 21 CFR 207 regulate?
  • Cosmetics are defined as articles intended for which of the following purposes?
  • What does a Pre-Sub Meeting provide to applicants?
  • What does FOIA stand for?
  • What requirement does FDAAA place upon direct-to-consumer advertisements?
  • What is the primary purpose of Phase III clinical trials?
  • What distinguishes a Traditional PMA from other submission methods?
  • What does the acronym "GCP" stand for in the context of clinical research regulations?
  • Labeling, as defined in regulatory affairs, includes which of the following?
  • What is the role of the Center for Devices and Radiological Health?
  • What distinguishes a Class II device from a Class I device?
  • What type of reports are included in Module 5 of the CTD?
  • Which document outlines a finished device’s design specifications?
  • What is the main focus of clinical protocols for phase 3 trials under the SPA?
  • What does the Product Development Process (PDP) primarily merge?
  • What was the primary purpose of the Nuremberg Code created in 1947?
  • What type of changes does a Real Time PMA Supplement address?
  • Which act establishes federal requirements for the privacy of health information?
  • 21 CFR parts 300s is related to which category of products?
  • What does IDE stand for in the context of regulatory affairs?
  • What does NDA stand for?
  • What governs ethical principles in medical research involving human subjects?
  • Which class of device is considered low-risk and requires general controls?
  • According to 21 CFR 807, what must manufacturers and initial distributors of medical devices do?
  • What is the main purpose of conducting a safety review within the 30-day hold period?
  • Which of the following describes Class III devices?
  • Which of the following is the Center for Drug Evaluation and Research abbreviated as?
  • What type of information is typically included in a Device Master File?
  • What is the intent of a device's Complaint definition?
  • What does QSR stand for in regulatory affairs?
  • What regulatory framework must medical device manufacturers comply with according to establishment listings?
  • Which phase of clinical trials involves the largest number of subjects?
  • Which type of drugs are referred to as Orphan Drugs?
  • What must generally be established to demonstrate that a biosimilar is "highly similar" to an existing product?
  • Which of the following is not an option available to an applicant if a device is deemed NSE?
  • Which classification is given to products that are incorrectly labeled?
  • Which legislative act primarily affects user fees in drug regulation?
  • What does 21 CFR parts 1-100 address?
  • What is an essential aspect of the consent form used in clinical trials?
  • 21 CFR parts 700s regulates which of the following?
  • What does PDUFA stand for?
  • What is required by the Pediatric Rule concerning drug products?
  • What does NSE indicate regarding a device submitted for evaluation?
  • What term is used for minor violations leading to firm-initiated product corrections?
  • What is covered under 21 CFR parts 600s?
  • What is typically required for Class III devices before market approval?
  • Which module would contain Non-Clinical Study Reports?
  • What does CBE-30 refer to in the context of submitting changes to the FDA?
  • Which center is focused on regulating devices and radiological health?
  • In regulatory affairs, what does an Institutional Review Board (IRB) primarily assess?
  • What is the main purpose of Post Marketing Surveillance (PMS)?
  • Which of the following describes a banned device according to FDA regulations?
  • What does IVD stand for in the regulatory context?
  • What does HCT/P stand for?
  • What does the expiration date on a product label signify?
  • How many subjects are typically involved in Phase II clinical trials?
  • What is the significance of the term "Grandfathered" in relation to regulatory compliance?
  • What is a key principle of Good Laboratory Practice (GLP)?
  • What is a significant requirement for drugs in an ANDA?
  • What does the Common Rule ensure regarding research protocols?
  • Which of the following would qualify as a biologic according to FDA definitions?
  • Which FDA aspect does the term "guidance" primarily relate to?
  • In which scenario is a Priority Review granted by the FDA?
  • What is one of the conditions for drugs to qualify under the Fast Track designation?
  • What does a Class I Recall imply about a device?
  • What does the abbreviation NDA stand for?
  • What is the primary focus of 21 CFR 814 Subpart H?
  • What is the primary purpose of an Advisory Committee for the FDA?
  • What is one of the primary functions of the Food and Drug Administration Safety and Innovation Act of 2012 (FDASIA)?
  • What is BIMO an acronym for within the context of FDA regulations?
  • What main aspect does the FDA Modernization Act enhance for drug studies?
  • Which Act emphasizes substantial equivalence for marketing applications of devices?
  • What is the primary function of a Special Protocol Assessment (SPA)?
  • What regulatory body is governed by 21 CFR 56?
  • What is a primary focus of the Declaration of Helsinki?
  • What does GLP stand for in regulatory affairs?
  • Which of the following defines a Complaint?
  • What is the main objective of the Product Development Process (PDP)?
  • What is the purpose of guidance documents published by the FDA?
  • What is the main characteristic of Phase IV studies?
  • What type of product does a Suitability Petition pertain to?
  • According to regulations, what defines a drug?
  • What is the purpose of a Certificate to Foreign Government?
  • Which of the following is NOT a responsibility under Good Clinical Practice (GCP)?
  • Which section outlines the criteria for Investigational Device Exemptions?
  • What type of market exclusivity does the Orphan Drug Act offer after FDA approval?
  • What role does the Division of Medication Error Prevention and Analysis (DMEPA) play?
  • Which factors determine the expiration period of a product?
  • What is a notable requirement of the FDAAA of 2007 regarding clinical trials?
  • What is the focus of 21 CFR parts 700s?
  • In which regulation would you find guidelines pertaining to drugs intended for animal use?
  • How long is the typical waiting period for a Type B meeting after a request?
Subscribe

Get the latest from Examzify

You can unsubscribe at any time. Read our privacy policy